On the world stage, President Donald Trump has long emphasized negotiating from a position of strength. He applied that same approach domestically with the creation of TrumpRx — a platform intended to...
In a recent interview, Novo Nordisk CEO Mike Rystar attributed the successful launch of the WGO pill to a combination of a strong product and dedicated personnel. He expressed confidence in the produc...
Novo Nordisk, the Danish pharmaceutical giant, reported robust first quarter earnings driven by strong sales of its weight management drug, Wegovy. The company raised its 2023 guidance for both adjust...
Pfizer CEO Albert Bourla discusses the company's strong first quarter results, driven by execution and a robust pipeline, particularly in cancer and obesity treatments. He highlights the company's foc...
Teva Pharmaceuticals, a global pharmaceutical company, reported strong first quarter results, with its innovative drug portfolio driving growth despite a decline in generic drug revenue. The company a...